InvestorsHub Logo
Followers 53
Posts 1789
Boards Moderated 0
Alias Born 03/22/2015

Re: None

Tuesday, 11/20/2018 9:28:38 PM

Tuesday, November 20, 2018 9:28:38 PM

Post# of 404141
Great day!





I love new approval days most of all. A real thing that we own that we didn't own before yesterday. And more to come! Soon! Filling the buckets, one ANDA at a time. And credit where credit is due: in the cases of Norco and Percocet, Nasrat turned a bad thing into something good. These ANDA's were originally developed as NDA's with 2 bead ADF. The FDA made clear they were not interested in ADF versions of the acetaminophen combination products, and so Nasrat then smartly transitioned to the non-ADF generics. It took time, but now here we are, and instead of jack squat, we've got these two shiny new ANDA's. Personally, I hope we eventually see NDA filings for the 2 bead ADF versions of these drugs, but the unfortunate truth is, these nonADF versions will probably make a shit-ton more money than the ADF versions ever would have.



I'm looking forward to the imminent approvals for the SunGen CNS stimulants, yet another example of management's foresight about problems in the ADF market. I agree ELTP's stagnant SP sucks, but I also know that other ADF companies are going down in flames while Elite's future has never looked better. Today is a great day for ELTP longs, and I credit Nasrat for it.





Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News